Skip to content

Direct hemoperfusion of protein-bound uremic toxins

Direct hemoperfusion of protein-bound uremic toxins - Protein-bound uremic toxin adsorption from blood

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000028465
Enrollment
10
Registered
2017-07-31
Start date
2017-01-16
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic kidney disease undergoing hemodialysis treatment

Interventions

None listed

Sponsors

Division of Blood Purification Therapy, Niigata University Medical and Dental Hospital
Lead Sponsor
Kureha Corporation,
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Chronic kidney disease patients undergoing maintenance hemodialysis treatment

Exclusion criteria

Exclusion criteria: Patients who treat infection. Pregnancy. Duration of dialysis treatment less than 1 year.

Design outcomes

Primary

MeasureTime frame
Change of blood level of several protein-bound uremic toxins in vitro

Secondary

MeasureTime frame
Change of other uremic toxins and electrolytes

Countries

Japan

Contacts

Public ContactSuguru Yamamoto

Niigata University Medical and Dental Hospital Division of Blood Purification Therapy

yamamots@med.niigata-u.ac.jp025-227-2770

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026